JPMorgan Chase & Co. Lowers Informa (LON:INF) Price Target to GBX 1,285

Informa (LON:INF) had its price target lowered by stock analysts at JPMorgan Chase & Co. from GBX 1,300 to GBX 1,285 in a research report issued to clients and investors on Thursday,London Stock Exchange reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 41.02% from the stock’s previous close.

Separately, Citigroup decreased their target price on Informa from GBX 1,000 to GBX 850 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Five research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, Informa currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,093.33.

Informa Trading Down 0.5%

Shares of INF opened at GBX 911.20 on Thursday. The company has a current ratio of 0.44, a quick ratio of 1.70 and a debt-to-equity ratio of 61.56. The company has a market cap of £11.47 billion, a P/E ratio of 1,139.00, a P/E/G ratio of 0.75 and a beta of 0.71. Informa has a twelve month low of GBX 719 and a twelve month high of GBX 1,000. The company’s fifty day simple moving average is GBX 824.98 and its 200-day simple moving average is GBX 831.37.

Insider Transactions at Informa

In other news, insider Gareth Wright acquired 222 shares of the stock in a transaction that occurred on Wednesday, May 20th. The shares were bought at an average cost of GBX 809 per share, for a total transaction of £1,795.98. Also, insider Stephen A. Carter acquired 222 shares of the business’s stock in a transaction on Wednesday, May 20th. The shares were purchased at an average price of GBX 809 per share, with a total value of £1,795.98. Company insiders own 0.23% of the company’s stock.

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.